PHC is a highly funded organisation that has been started by Mr. Andreas Tausch in 2008 with Pathelen being the main focus as its first medical device to be marketed, with other very effective products pending.
The R&D phase of Pathelen began 10 years ago when Mr. Tausch, a Biochemist and Philanthropist, invented the original ground-breaking formula, through his extensive knowledge of biochemistry and interest in helping people and change the way we approach wound treatment, and refined, tested and patented the formula to its present marketable state.
From the beginning of R&D, Mr. Tausch worked within European guidelines in order to secure European registration. Then, in August 2017, Pathelen got in touch with Unitas to help develop a strategy to launch and sell Pathelen under the radar of the big Pharmaceutical giants to prevent their interference and stopping the drug from ever being launched. Due to the close and strong relationships with Governments Unitas started the Pathelen registration of Pathelen within target territories Ghana and Nigeria as a launch pad, targeting NHS, private and Military Hospitals within those countries.
Background Information on Pathelen® Wundpulver
Pathelen is based on a drug, which has been specifically designed and developed for the treatment of multi-resistant bacteria (such as MRSA) in open wounds. Pathelen generally eliminates most external bacterial wound infections within 5-10 days i.e. to prepare the treated wound for a wound closure surgery and/or enhance the growth of granulating tissue on the treated wound.
The drug has a wide range of anti-microbic action, high activity as in regard to gram-positive and gram-negative aerobic and anaerobic microorganisms (clostridial and non-clostridial in composition with aerobic and facultative anaerobic).
Typical problematic germs which can be treated with Pathelen®are:
Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), Enterobacteria i.e. – Escherichia coli – Klebsiella pneumoniae – Klebsiella oxytoca, Proteus mirabilis, Non-fermenting organisms i.e. Pseudomonas aeruginosa – Acinetobacter baumannii – Pseudomonas
Expertise. Experience. Dedication.
Prinz Karl Thurn und Taxis Management AG is a Swiss based investment, advisory, and asset management company which
Offers professional real estate management and family offices as a service and invests in major real estate developments;
Organises local support and advise in the oil and gas industry as well as in sustainable power projects and invests in joint ventures with major players in these industries;
Provides financial services by raising funds and investing in all kinds of projects in the main focus areas of the company.
Brewed by the Locher family at the foot of the Swiss Alps using only the purest water, 1936 Bière has a unique, fresh and ultra clean taste.
The water used to brew 1936 Bière filters through the Swiss Alps, taking up to 25 years to reach the source. This unique water is combined with raw ingredients – Swiss hops and golden barley grown at high altitude on the mountains – to create a beer totally free from artificial preservatives or additives. Long famous for its innovative prowess in the development of new beers, the 1936 Bière brewery also leads in the field of climate protection.
This increases sales
Providing accountancy services for more than 75 restaurants in the UK
Services: weekly management accounts, monthly management report and accounts, payroll, tronc scheme service, supplier invoice payments, completing vat return, reconciling cash and bank balances are just some of the services we provide
‘Providers of high quality book keeping and accounting information essential to the successful running of any business’.